Immuneering Corporation is conducting a global Phase 3 trial called MAPKeeper 301 to evaluate atebimetinib combined with modified gemcitabine and nab-paclitaxel versus standard chemotherapy in first-line metastatic pancreatic cancer. This trial follows promising Phase 2a results showing a median overall survival of 17.3 months, which is better than historical outcomes. The study aims to confirm if atebimetinib can extend survival with fewer side effects and better quality of life. Patient recruitment began in June 2026, and results are highly anticipated as pancreatic cancer treatments urgently need improvement.
Immuneering's Phase 3 MAPKeeper 301 trial is the focus here, with Pluang providing a snapshot of the health sector as of Oct 26, 2026 18:11 WIB: Among 150 priced US health stocks, 82 rose and 35 fell. Inovio Pharmaceuticals Inc (INO) gained 4.55% to USD 0.94 with a typical hold time of 43 days, contrasting with Amylx Pharmaceuticals Inc (AMLX) which rose 4.23% to USD 28.35 and a shorter hold time of 16 days, while Abeona Therapeutics Inc (ABEO) increased 3.18% to USD 4.54 with a 27-day hold time.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
